Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nicholas T Bello

Showing results (1-10 of 67) with videos related to

Pageof 7
Sort By:
Patient Preference and Adherence|July 15, 2015
Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsNicholas T Bello
Expert Opinion on Drug Safety|May 17, 2019
Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesityNicholas T Bello
Pharmacology, Biochemistry, and Behavior|April 27, 2010
Dopamine and binge eating behaviorsNicholas T Bello, Andras Hajnal
Nutrition Research (New York, N.Y.)|July 1, 2006
Male rats show an indifference-avoidance response for increasing concentrations of the artificial sweetener sucraloseNicholas T Bello, Andras Hajnal
Nutrients|April 13, 2023
Sex-Specific Effects on Total Body Fat Gain with 4-Week Daily Dosing of Raspberry Ketone [4-(4-Hydroxyphenyl)-2-butanone] and Ketogenic Diet in MiceLihong Hao, Nicholas T Bello
Frontiers in Physiology|December 10, 2021
Reduced Body Fat and Epididymal Adipose <i>Apelin</i> Expression Associated With Raspberry Ketone [4-(4-Hydroxyphenyl)-2-Butanone] Weight Gain Prevention in High-Fat-Diet Fed MiceLihong Hao, Nicholas T Bello
Physiology & Behavior|May 9, 2006
Alterations in blood glucose levels under hyperinsulinemia affect accumbens dopamineNicholas T Bello, Andras Hajnal
Expert Opinion on Pharmacotherapy|November 26, 2019
Anorectic state of obesity medications in the United States. Are leaner times ahead?Xinyi Li, Nicholas T Bello
Drug Design, Development and Therapy|March 31, 2011
The use of serotonergic drugs to treat obesity--is there any hope?Nicholas T Bello, Nu-Chu Liang
Expert Review of Clinical Pharmacology|September 4, 2016
Can we win the war on obesity with pharmacotherapy?Juliet D Gotthardt, Nicholas T Bello
Pageof 7

Showing results (1-10 of 67) with videos related to

Sort By:
Pageof 7
Patient Preference and Adherence|July 15, 2015
Clinical utility of guanfacine extended release in the treatment of ADHD in children and adolescentsNicholas T Bello
Expert Opinion on Drug Safety|May 17, 2019
Update on drug safety evaluation of naltrexone/bupropion for the treatment of obesityNicholas T Bello
Pharmacology, Biochemistry, and Behavior|April 27, 2010
Dopamine and binge eating behaviorsNicholas T Bello, Andras Hajnal
Nutrition Research (New York, N.Y.)|July 1, 2006
Male rats show an indifference-avoidance response for increasing concentrations of the artificial sweetener sucraloseNicholas T Bello, Andras Hajnal
Nutrients|April 13, 2023
Sex-Specific Effects on Total Body Fat Gain with 4-Week Daily Dosing of Raspberry Ketone [4-(4-Hydroxyphenyl)-2-butanone] and Ketogenic Diet in MiceLihong Hao, Nicholas T Bello
Frontiers in Physiology|December 10, 2021
Reduced Body Fat and Epididymal Adipose <i>Apelin</i> Expression Associated With Raspberry Ketone [4-(4-Hydroxyphenyl)-2-Butanone] Weight Gain Prevention in High-Fat-Diet Fed MiceLihong Hao, Nicholas T Bello
Physiology & Behavior|May 9, 2006
Alterations in blood glucose levels under hyperinsulinemia affect accumbens dopamineNicholas T Bello, Andras Hajnal
Expert Opinion on Pharmacotherapy|November 26, 2019
Anorectic state of obesity medications in the United States. Are leaner times ahead?Xinyi Li, Nicholas T Bello
Drug Design, Development and Therapy|March 31, 2011
The use of serotonergic drugs to treat obesity--is there any hope?Nicholas T Bello, Nu-Chu Liang
Expert Review of Clinical Pharmacology|September 4, 2016
Can we win the war on obesity with pharmacotherapy?Juliet D Gotthardt, Nicholas T Bello
Pageof 7